Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
VRTXCash & Equivalents Over Time
Trending lower, strong compound growth.
Left:
|||
Cash on hand plus short-term liquid investments
Latest
$4.57B
Near historical average
Average (9y)
$4.75B
Historical baseline
Range
High:$10.50B
Low:$714.77M
CAGR
+22.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $4.57B | -55.9% |
| 2023 | $10.37B | -1.3% |
| 2022 | $10.50B | +54.6% |
| 2021 | $6.79B | +13.5% |
| 2020 | $5.99B | +92.6% |
| 2019 | $3.11B | +17.3% |
| 2018 | $2.65B | +59.1% |
| 2017 | $1.67B | +40.7% |
| 2016 | $1.18B | +65.6% |
| 2015 | $714.77M | - |